The Fourth International Leukocyte Signal Transduction Workshop: Clinical Implica
The Fourth International Leukocyte Signal Transduction Workshop: Clinical Implica
批准号:
7278001
负责人:
AMNON ALTMAN
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-15 至 2008-04-30
关键词:
Animal Disease ModelsAnimal ModelAreaAutoimmune DiseasesAutoimmunityBiochemicalCellsClinicalCollaborationsCommitCommunicable DiseasesComplexDevelopmentDiseaseDisease modelEducational workshopFacultyFundingGenesGreeceHumanImmune System DiseasesImmune responseInflammationInflammatoryInternationalLeadLeukocytesMotivationMusMutationParticipantPathway interactionsRangeResearchScientistSeriesSignal PathwaySignal TransductionStagingStudentsTechnologyTimeWorkcareercell typeclinical applicationclinically relevantexperiencegenetic manipulationinsightmemberpreventprofessorprogramsreceptorsymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A proper immune response depends on complex interactions between different leukocytes and other cell
types and their soluble products, and on an intensive crosstalk among many receptors, which transduce
activation signals leading to induction of cell-specific gene programs, differentiation, proliferation, and
acquisition of effector functions. A dysregulated immune response can lead to harmful results, the
development of autoimmune diseases being a prime example. Aberrant mechanisms that lead to
development of inflammation and autoimmunity have been elucidated to a large degree by the genetic
manipulation of mice, which led to significant insights into the underlying signaling mechanisms. Thus,
genetic alteration of signaling pathways at defined steps can prevent or induce the development of
autoimmunity and other immunological diseases. Nevertheless, small scientific meetings that allow
intensive interactions and fruitful discussions and, at the same time, bring together scientists working on
fundamental aspects of leukocyte signaling pathways and on the clinical implications of these pathways
(including relevant disease models) are far and few between.
Funds are requested to support an international conference entitled ?The 4th International Leukocyte Signal
Transduction Workshop: Clinical Implications of Signaling Pathways? to be held in Rhodes, Greece,
between 6/3-8/07. This is the 4th in a series of similar meetings, which were held since 2000. Previous
meetings focused exclusively on basic aspects of signal transduction by leukocyte receptors. The
upcoming meeting, with ~120 anticipated participants, will represent a significant departure from this focus.
The Organizing Committee has drafted this time a program, which brings together scientists working on
fundamental aspects of leukocyte signaling and those studying relevant animal disease models and clinical
implications of these signaling pathways. In addition, several invited talks will present and discuss relevant
cutting edge technologies. The invited faculty consists of 23 internationally known scientists (in addition to
the Organizing Committee) who are recognized experts in relevant research areas. Scientists at the early,
formative stage of their career will be given priority in participation and presentation. Together, the
scientists participating in this Workshop cover different areas of research, which encompass a
comprehensive range, from the subcellular, biochemical level of analysis, through whole cell and animal
models, and up to clinical applications.
The Specific Aims of the Workshop are:
1. Extend and continue three previous, highly productive Leukocyte Signal Transduction Workshops.
2. Bring together internationally known scientists, who are experts in leukocyte signal transduction and
the disease implications of leukocyte signaling pathways to, e.g., inflammation, autoimmunity, and
infectious disease, in order to present and discuss the most up-to-date relevant research.
3. Give scientists at an early stage of their formative career, i.e., junior faculty members (assistant
professors), postdoctoral research fellows and graduate students an opportunity to present and discuss
their own ongoing work and to benefit from close, one-on-one interactions with leading scientists, thereby
providing an educational experience and a motivation to commit themselves to a clinically relevant
scientific research career.
The Organizers anticipate that this Workshop will promote sharing of ideas, close interactions and
collaborations between scientists working on basic aspects of leukocyte signaling and those studying
animal model (or even human) inflammatory and autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of Teff/Treg cells by novel PKC-theta allosteric inhibitory strategies
-
批准号:8771233
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2014
-
负责人:AMNON ALTMAN
-
依托单位:
7th International Leukocyte Signal Transduction Conference
-
批准号:8594061
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2013
-
负责人:AMNON ALTMAN
-
依托单位:
Global protein palmitoylation and DHHC proteins in T cell activation and anergy
-
批准号:8238986
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
The 6th International Leukocyte Signal Transduction Workshop
-
批准号:8205423
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
Global protein palmitoylation and DHHC proteins in T cell activation and anergy
-
批准号:8766542
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
Global protein palmitoylation and DHHC proteins in T cell activation and anergy
-
批准号:8385513
-
项目类别:
-
资助金额:$41.92万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
Global protein palmitoylation and DHHC proteins in T cell activation and anergy
-
批准号:8590200
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2011
-
负责人:AMNON ALTMAN
-
依托单位:
Regulation of T cell anergy by palmitoyl acyl transferases
-
批准号:7753678
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2009
-
负责人:AMNON ALTMAN
-
依托单位:
The 5th International Leukocyte Signal Transduction Workshop
-
批准号:7688398
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2009
-
负责人:AMNON ALTMAN
-
依托单位:
Regulation of T cell anergy by palmitoyl acyl transferases
-
批准号:7571748
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2009
-
负责人:AMNON ALTMAN
-
依托单位:
Immune regulation by SLAT, a Novel Th2-Expressed Protein
-
批准号:7771711
-
项目类别:
-
资助金额:$44.75万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
SLAT: A novel GEF coordinating actin remodeling and Ca2+ signaling in T cells
-
批准号:8041138
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
SLAT: A novel GEF coordinating actin remodeling and Ca2+ signaling in T cells
-
批准号:8432835
-
项目类别:
-
资助金额:$42.72万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
Immune regulation by SLAT, a Novel Th2-Expressed Protein
-
批准号:7570019
-
项目类别:
-
资助金额:$45.2万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
SLAT: A novel GEF coordinating actin remodeling and Ca2+ signaling in T cells
-
批准号:8619577
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
Immune regulation by SLAT, a Novel Th2-Expressed Protein
-
批准号:7049873
-
项目类别:
-
资助金额:$47.45万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
Immune regulation by SLAT, a Novel Th2-Expressed Protein
-
批准号:7379906
-
项目类别:
-
资助金额:$45.2万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
Immune regulation by SLAT, a Novel Th2-Expressed Protein
-
批准号:7187391
-
项目类别:
-
资助金额:$46.07万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
SLAT: A novel GEF coordinating actin remodeling and Ca2+ signaling in T cells
-
批准号:8206605
-
项目类别:
-
资助金额:$45.45万
-
财政年份:2006
-
负责人:AMNON ALTMAN
-
依托单位:
PKC Theta--A Novel Drug Target in T Cell Leukemias
-
批准号:6466120
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2002
-
负责人:AMNON ALTMAN
-
依托单位:
海外基金